Search Data.gov
Found 62 dataset(s) matching "clinic production".
-
This dataset lists the reasons for medical non-production by each Dept of Correction facility each month. The columns in the dataset are reasons why a person in custody is not produced for a...
-
<p>Effective management of Pathology and Laboratory Medicine Service (P&LMS) laboratories requires indicators capable of demonstrating each individual laboratory's productivity and efficiency....
-
Background There is considerable uncertainty about the future of undergraduate medical education in the face of several important challenges. This paper highlights many of the...
-
This product consists of multiple tabular datasets and associated metadata for clinical status, gene transcripts, and lab results related to presence of Mycoplasma spp. in desert reptiles. To...
-
Provides information to the public on postmarket requirements and commitments. The phrase postmarket requirements and commitments refers to studies and clinical trials that sponsors conduct after...
-
Background High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical...
-
Compounds of formula (I) for clinical treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection and malignant neoplasia. A pharmaceutical composition comprising a...
-
Background Reliability cannot be achieved in a clinical laboratory through the control of accuracy in the analytical phase of the testing process alone. Indeed a "mistake" can be defined...
-
Early approaches to the development of oxygen carriers involved the use of stroma-free hemoglobin solutions. These solutions did not require blood typing or crossmatching and could be stored...
-
Background The effect of silicones on the immune function is not fully characterized. In clinical and experimental studies, immune alterations associated with silicone gel seem to be...
-
The Medicare Part B by Drug dataset presents information on spending for drugs administered in doctors’ offices and other outpatient settings by physicians and other healthcare providers to...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC) in collaboration with the United States Consumer Product...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), and Centers for Disease Control and Prevention (CDC), in collaboration with the United States...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC) in collaboration with the United States Consumer Product...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC) in collaboration with the United States Consumer Product...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), and Centers for Disease Control and Prevention (CDC), in collaboration with the United States...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), and Centers for Disease Control and Prevention (CDC), in collaboration with the United States...
-
Beginning in July 2000, the National Center for Injury Prevention and Control (NCIPC), and Centers for Disease Control and Prevention (CDC), in collaboration with the United States...
